Chemoinformaics analysis of (2e,15z)-14-methyl-2,15-octadecadien-1-ol
Molecular Weight | 280.496 | nRot | 14 |
Heavy Atom Molecular Weight | 244.208 | nRig | 2 |
Exact Molecular Weight | 280.277 | nRing | 0 |
Solubility: LogS | -4.276 | nHRing | 0 |
Solubility: LogP | 6.4 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 56.5365 |
nHD | 1 | BPOL | 36.1155 |
QED | 0.304 |
Synth | 3.071 |
Natural Product Likeliness | 2.08 |
NR-PPAR-gamma | 0.1 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.029 |
CACO-2 | -4.834 |
MDCK | 0.0000297 |
BBB | 0.269 |
PPB | 0.986242 |
VDSS | 4.538 |
FU | 0.00771692 |
CYP1A2-inh | 0.374 |
CYP1A2-sub | 0.275 |
CYP2c19-inh | 0.287 |
CYP2c19-sub | 0.062 |
CYP2c9-inh | 0.26 |
CYP2c9-sub | 0.962 |
CYP2d6-inh | 0.367 |
CYP2d6-sub | 0.818 |
CYP3a4-inh | 0.654 |
CYP3a4-sub | 0.101 |
CL | 4.513 |
T12 | 0.784 |
hERG | 0.08 |
Ames | 0.005 |
ROA | 0.026 |
SkinSen | 0.955 |
Carcinogencity | 0.037 |
EI | 0.983 |
Respiratory | 0.157 |
NR-Aromatase | 0.101 |
Antiviral | Yes |
Prediction | 0.735896 |